Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Pharma
FDA grants full approval to Novartis' Fabhalta in IgAN
The FDA has converted its accelerated approval for Novartis' Fabhalta to a full blessing to treat patients with immunoglobulin A nephropathy.
Kevin Dunleavy
Jul 17, 2026 11:33am
Regulatory tracker: Boehringer's Jascayd wins nod in Europe
Jul 17, 2026 11:20am
Designing an agentic, future‑ready tech roadmap for emerging pharma
Brought to you by
ZS
Novo, Alvotech written up after FDA site inspections
Jul 17, 2026 10:56am
Pharma marketers face privacy hurdles, turn to omnichannel strategies
Brought to you by
Swoop
The Oral GLP-1 Tracker: Lilly’s Foundayo scripts tick up
Jul 17, 2026 10:30am
